Biofoundry-As-A-Service Market Growth Forecast Through 2030: Market Size And Trends In 2026
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biofoundry-As-A-Service Market Revenue Growth On Track For A 21.6% CAGR Through 2030
The biofoundry-as-a-service market has experienced significant expansion over recent years. Projections indicate its value will increase from $1.65 billion in 2025 to $2.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.3%. Historically, this growth can be ascribed to several factors, including increasing investment in synthetic biology, the adoption of automated laboratory equipment, rising demand for genetic engineering services, the growth of academic and research institutes, and the expansion of biotechnology companies.
The biofoundry-as-a-service market size is projected to experience substantial growth in the coming years, reaching $4.38 billion by 2030 with a compound annual growth rate (CAGR) of 21.6%. This expansion during the forecast period can be attributed to the increasing deployment of AI-driven biofoundry platforms, the growing adoption of cloud-based design-build-test-learn services, a rising demand for integrated bioengineering solutions, the broadening of pharmaceutical and industrial biotechnology applications, and an increasing focus on scalable and high-throughput biofoundry operations. Key trends for the forecast period include the increasing uptake of end-to-end DBTL cycle services, a rising demand for automated DNA assembly services, the growing integration of machine learning modeling in biofoundries, the expansion of platform-as-a-service bioengineering solutions, and a rising focus on high-throughput phenotypic and genotypic testing.
Get A Free Sample Report With In-Depth Market Insights:
Biofoundry-As-A-Service Market Growth Backed By Core Demand Fundamentals
The increasing financial commitments in life sciences are projected to boost the expansion of the biofoundry-as-a-service market in the future. These life sciences investments involve providing capital to enterprises, research initiatives, and technological developments primarily within healthcare, biotechnology, pharmaceuticals, medical devices, and related biological advancements. Such investments are expanding due to an escalating need for sophisticated healthcare solutions, driven by a growing population requiring novel treatments, tailored medicine, and state-of-the-art technologies to manage intricate diseases and enhance general health results. This capital influx into life sciences fuels the biofoundry-as-a-service market by supplying essential funds for creating advanced automated systems, speeding up high-throughput biological investigations, and facilitating scalable, adaptable offerings for both biotechnology firms and academic entities. As an illustration, in September 2025, the Association of the British Pharmaceutical Industry (ABPI), a UK-based non-profit body, reported that the UK government pledged to allocate up to $707 million (£520 million) in capital grants. This commitment aims to back inward investment in advanced life sciences manufacturing, thus solidifying the nation’s standing as a premier center for innovation in life sciences. Consequently, the increased financial input into life sciences is propelling the expansion of the biofoundry-as-a-service market.
Biofoundry-As-A-Service Market Segment Performance And Emerging Opportunities
The biofoundry-as-a-service market covered in this report is segmented –
1) By Service Type: Design, Build, Test, Learn, Integrated Services
2) By Application: Pharmaceuticals, Agriculture, Industrial Biotechnology, Environmental, Other Applications
3) By End-User: Academic And Research Institutes, Biotechnology Companies, Pharmaceutical Companies, Other End Users
Subsegments:
1) By Design: Pathway Design Services, Genetic Circuit Design Services, Strain Design And Optimization Services, Metabolic Engineering Design Services
2) By Build: Automated DNA Assembly Services, Strain Construction Services, Plasmid And Vector Construction Services, Synthetic Gene Synthesis Services
3) By Test: High-Throughput Screening Services, Phenotypic Characterization Services, Genotypic Validation Services, Assay Development And Testing Services
4) By Learn: Data Analysis And Interpretation Services, Machine Learning Modeling Services, Optimization And Feedback Services, Experimental Data Integration Services
5) By Integrated Services: End-to-End Biofoundry Services, Design-Build-Test-Learn (DBTL) Cycle Services, Custom Bioengineering Project Services, Platform-As-A-Service Integrated Solutions
Biofoundry-As-A-Service Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the biofoundry-as-a-service market are concentrating on deploying modular, automated biofoundry platforms. This effort aims to speed up biologics development, streamline process optimization, and improve scalable manufacturing capabilities. These modular, automated biofoundry platforms are advanced laboratory systems that integrate robotics, artificial intelligence–enabled software, and standardized biological processes, allowing for the streamlined design, construction, testing, and optimization of biological systems with minimal manual input. For example, in November 2024, Quotient Sciences, a UK-based drug development and manufacturing accelerator, installed Centillion’s GMP Biofoundry-in-a-Box platform to expand its integrated drug development and manufacturing services. This installation enhances the company’s capability to deliver automated, high-throughput biologics development and GMP-compliant production, providing clients with accelerated timelines, improved reproducibility, and scalable therapeutic manufacturing solutions.
Biofoundry-As-A-Service Market Key Participants And Competitive Landscape
Major companies operating in the biofoundry-as-a-service market are GenScript Biotech Corporation, Ginkgo Bioworks Holdings Inc., Twist Bioscience Corporation, Codexis Inc., Emerald Cloud Lab Inc., Synbio Technologies LLC, Automata Technologies Limited, Telesis Bio Inc., Culture Biosciences Inc., Bioneer Corporation, Earlham Biofoundry Ltd., Arzeda Corporation, LabGenius Limited, Conagen Inc., Bota Biosciences Inc., Arctoris Ltd., Evonetix Ltd., Absci Corporation, TeselaGen Biotechnology Inc., SynbiCITE Innovation Hub.
View The Full Biofoundry-As-A-Service Market Report:
Biofoundry-As-A-Service Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the biofoundry-as-a-service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biofoundry-as-a-service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
